Chemotherapy of advanced NSCLC in the elderly

Tumori

Volumn 88, Issue SUPPL. 1, 2002, Pages

  Gridelli, Cesare ^a   Ferrara, Carmine ^a   Del Gaizo, Filomena ^a   Guerriero, Ciro ^a   Nicolella, Dario ^a   Colantuoni, Giuseppe ^a   Rossi, Antonio ^a  

^a S G MOSCATI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; NAVELBINE;

ADVANCED CANCER; AGED; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LUNG NON SMALL CELL CANCER; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; VOMITING;

EID: 0036201259     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800142     Document Type: Conference Paper

References (14)

1. Lung cancer in the elderly
2. The National Cancer Institute on Aging and the National Cancer Institute SEER. Collaborative study on comorbidity and early diagnosis of cancer in the elderly
3. Cancer in the elderly: Why so badly treated?
4. Chemotherapy of advanced non small cell lung cancer in the elderly: An update
5. Chemotherapy in non small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
6. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non small cell lung cancer. A two-stage phase II study
7. Effect of vinorelbine on quality of life and survival of elderly patients with advanced non small cell lung cancer
8. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non small cell lung cancer elderly patients: A phase II data from Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial
9. A phase II clinical and pharmacokinetic study of weekly paclitaxel in elderly patients with non small cell lung cancer
10. Weekly docetaxel in the treatment of elderly patients with advanced non small cell lung carcinoma
11. Correlation between age and prognosis in patients with advanced non small cell lung cancer (NSCLC) treated with cisplatin (CDDP) containing chemotherapy: A retrospective multicenter study
12. Gemcitabine plus vinorelbine in elderly or unfit patients with non small cell lung cancer
13. Weekly docetaxel/gemcitabine in the treatment of elderly patients with advanced non small cell lung cancer: A Minnie Pearl Cancer Research phase II trial
14. The MILES (Multi-center Italian Lung Cancer in the Elderly Study) phase 3 trial: Gemcitabine + vinorelbine vs vinorelbine and vs gemcitabine in elderly advanced NSCLC patients